Alx Oncology Holdings Inc (NASDAQ: ALXO) on Monday, soared 15.43% from the previous trading day, before settling in for the closing price of $1.62. Within the past 52 weeks, ALXO’s price has moved between $1.19 and $17.83.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -8.67% over the past five years. The company achieved an average annual earnings per share of 26.31%. With a float of $34.33 million, this company’s outstanding shares have now reached $52.74 million.
Let’s look at the performance matrix of the company that is accounted for 72 employees. In terms of profitability, gross margin is 74.15%, operating margin of -6446.65%, and the pretax margin is -6095.12%.
Alx Oncology Holdings Inc (ALXO) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Alx Oncology Holdings Inc is 34.92%, while institutional ownership is 58.48%. The most recent insider transaction that took place on Dec 02 ’24, was worth 46,404. In this transaction Director of this company bought 30,000 shares at a rate of $1.55, taking the stock ownership to the 33,000 shares. Before that another transaction happened on Aug 14 ’24, when Company’s SVP, FINANCE AND CAO sold 564 for $2.58, making the entire transaction worth $1,455. This insider now owns 91,549 shares in total.
Alx Oncology Holdings Inc (ALXO) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.82 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 26.31% per share during the next fiscal year.
Alx Oncology Holdings Inc (NASDAQ: ALXO) Trading Performance Indicators
Alx Oncology Holdings Inc (ALXO) is currently performing well based on its current performance indicators. A quick ratio of 4.82 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.98, a number that is poised to hit -0.67 in the next quarter and is forecasted to reach -2.50 in one year’s time.
Technical Analysis of Alx Oncology Holdings Inc (ALXO)
Alx Oncology Holdings Inc (NASDAQ: ALXO) saw its 5-day average volume 2.34 million, a positive change from its year-to-date volume of 0.83 million. As of the previous 9 days, the stock’s Stochastic %D was 39.49%. Additionally, its Average True Range was 0.20.
During the past 100 days, Alx Oncology Holdings Inc’s (ALXO) raw stochastic average was set at 37.16%, which indicates a significant decrease from 72.31% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 165.28% in the past 14 days, which was higher than the 92.36% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4995, while its 200-day Moving Average is $6.3330. Nevertheless, the first resistance level for the watch stands at $1.9900 in the near term. At $2.1100, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.2900. If the price goes on to break the first support level at $1.6900, it is likely to go to the next support level at $1.5100. The third support level lies at $1.3900 if the price breaches the second support level.
Alx Oncology Holdings Inc (NASDAQ: ALXO) Key Stats
Market capitalization of the company is 98.63 million based on 52,743K outstanding shares. Right now, sales total 0 K and income totals -160,810 K. The company made 0 K in profit during its latest quarter, and -30,710 K in sales during its previous quarter.
